Trial Details

TERMINATED
Basic Information
Clinical ID c3318
Identifier NCT02239926
Trial Title Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Diarrhea Predominant Irritable Bowel Syndrome
Interventions DRUG: Ranolazine|DRUG: Placebo
Participant Information
Sponsor Mayo Clinic
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2014-09
Primary Completion Date 2015-09
Completion Date 2015-09